Stockreport

Agenus AGM: Bot/Bal Combo Targets “Cold” MSS Colorectal Cancer as Phase III BATMAN Trial Launches [Yahoo! Finance]

Agenus Inc.  (AGEN) 
Last agenus inc. earnings: 3/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: agenusbio.com/investors
PDF combination in refractory MSS metastatic colorectal cancer , with overall survival as the primary endpoint and the study powered to assess both liver and non-liver metas [Read more]